Persistence Market Research in its newly published report titled “MicroRNA Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),” provides forecast and analysis of the global microRNA market on the global and regional levels. Through an extensive research, our analysts have studied how the different market dynamics are likely to impact the current and future scenario of the global microRNA market, thereby providing useful insights to market players to plan their differentiating strategies, capable of evolving with the changing market landscape. We have analyzed the key trends, drivers, restraints and opportunities while studying this report. Impact analysis of key growth drivers and restraints based on the weighted average model are included in the report to better equip and arm clients with crystal-clear and decision-making insights.
The report has indicated the segment wise definition of the market along with its overall scenario in the assessment period. The publication focuses on to identify opportunities in the market and present updates and insights, pertaining to the various segments of the global microRNA market. While researching this report, market splits have been deduced from a survey and primary research. This report provides historical data of 2012-2016 along with forecast from 2017 to 2025 in terms of revenue (US$ Dollar).
The global microRNA market report begins with the definition of the market and relevance and impact of forecast factors used to estimate the global microRNA market growth. It is followed by an overview of market dynamics of the global microRNA market, which includes Persistence Market Research’s analysis of key trends, drivers, restraints and opportunities that are influencing the development of the global microRNA market. Impact analysis of key growth drivers and restraints based on the weighted average model has been included at a regional level in the global market report after detailed analysis of individual regions to better equip readers with meaningful insights on ongoing developments in the global microRNA market.
In the final section of the report on the global microRNA market, detailed profiles of life sciences laboratories are included to evaluate their long- and short-term strategies, key offerings, SWOT analysis, and recent developments in the global microRNA market.
The forecast presented in this report assesses the total revenue of the global microRNA market. When developing the market forecast, the starting point involves sizing the current market, which forms the basis for the forecast of how the market is anticipated to take shape in the near future. Given the characteristics of the market, the analysts have triangulated the outcome on the basis of analysis based on supply and demand sides. The report also takes into consideration year-on-year growth to understand the predictability of the market and to identify the right opportunities across the global microRNA market. As previously highlighted, the global market for microRNA is split into various categories. All these segments have been analyzed in terms of basis point share to understand segmental contribution to overall market growth. This detailed level of information is important to identify various key trends in the global microRNA market.
Macro-economic indicators such as life science reagents and tools market outlook, expenditure on life science research, Gross Domestic Product and others has been considered to arrive at the indicated market numbers. Bottom-up approach has been used to assess market numbers for each product category while the top-down approach has been used to counter-validate the estimated market numbers. Historical trend has been analyzed to track data.
Global microRNA market is fragmented due to the presence of various companies in the market
Global microRNA market is highly fragmented owing to presence of various companies, especially domestic players creating immense price competition. Thermo Fisher Scientific Inc. is the leader in the global microRNA market in terms of revenue share in 2016 due to a wide product portfolio. Thermo Fisher Scientific Inc. grabbed major market share as it offers both miRNA reagents and the hardware required for carrying out theses assays. Thermo Fisher Scientific Inc. also offers microRNA products specifically catering to the animal health and agriculture segment. Hence its wide product range catering to different end-users makes it a market leader in the microRNA market.
Illumina Inc., takes second position in the global microRNA market. The company has microarray kits and library preparation kits for miRNA. Moreover, NGS of miRNAs is coming into wider use and provides unmatched efficacy in discovering and detecting miRNA. Agilent Technologies, Inc. follows Illumina Inc. with a market share of 7.5%. The company manufactures microarrays and has recently developed a new application for studying miRNAs by combining miRNA method with SurePrint inkjet synthesis technology.
Due to tremendous development in the technologies used in PCR, the market players are offering PCR with higher sensitivity
This kind of PCR amplifies a given target for some future use, such as DNA sequencing or microsatellite analysis. Gel electrophoresis can tell users if they’ve made a product or not, and the size of that product.
Quantitative PCR (qPCR)
This variation on the methodology evolved as the need for more accurate results required more detailed quantitation of the material produced. Quantitative PCR enables scientists, to watch every cycle of the chain reaction, via fluorescence markers. Every cycle should about double the amount of target DNA present.
Digital PCR involves splitting a PCR reaction into thousands or millions of individual partitions, ideally such that each one contains either zero or one copy of the target DNA. Each partition is a simple endpoint reaction. It’s digital in the sense that each of the PCR reactions either has, or does not have, a product.
Diversification of product offerings to cater to different industry verticals are key to be able to differentiate and gain market share
There has been a shift from investment in R&D and technology, especially in life sciences and biotechnology, from North America and Europe to Asia Pacific. Emerging economies such as India have ample skilled labor and qualified manpower at affordable costs thereby increasing the scope for attracting outsourcing of biotech projects. Additionally, several governments in these regions have started taking initiatives to support growth of the domestic biotechnology industry by offering tax exemptions for R&D, increased budgets and funding, creating public and private conglomerates and attracting foreign direct investments.
Despite the market having several large players as well as multiple smaller companies, there are limited companies that have a complete focus on being a provider of reagents for research and diagnostic use. Different vendors have different specializations and product offerings, with most large companies combining research products and reagents with equipment, in-vitro diagnostics tools.
PCR based arrays segment is expected to be the most lucrative among all assay type segments, with an attractiveness index of 1.6
PCR based arrays dominated the global microRNA market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. PCR based arrays segment is expected to be the most lucrative among all end users, with attractiveness index of 1.6. On the other hand, next generation sequencing is one of the segments in global microRNA market that is estimated to represent US$ 100.4 Mn of the total market in 2017 and is estimated to reach US$ 187.8 Mn by 2025 end, expanding at CAGR of 8.1% over the forecast period of 2017–2025.